13-Oct-15 As China's growing 40+ population suffers increasingly from lifestyle diseases such as cardiac problems and cancer, many of the wealthy among them will seek treatment in the US or Europe. And many more will spend some of their new found wealth on plastic surgery, dentistry or wellness programs in Korea or Southeast Asia. Chinese medical tourists spent USD10 bn in 2014, only 2.3% of the global total, suggesting that there is a huge potential for further growth in the market. What can hospitals and governments do to tap into this opportunity? [image: Travel Daily News]

18-Nov-15 UK healthcare providers and elderly care companies are seeking business opportunities in China to tap the rising demand for elderly care. Tunstall Healthcare, a UK health technology firm, is opening a showroom in Shanghai to showcase its health monitoring capabilities. The UK's IHG is building a hospital in South China for China Railway Engineering Corp, while Annie Barr, Glasgow Caledonian University and Kings College London are training Chinese health professionals in five cities as China aims to train 150,000 doctors and 2 million nurses by 2020. [image: Venture Capital Post]

17-Nov-15 King's College Hospital has become the clinical partner for the first Indo UK Institute of Health, in New Chandigar, India. Backed by up to GBP100 mn of private investment, the project is the first of 11 which will see hospitals, nursing schools and medical colleges developed across India. The initiative will eventually amount to a GBP1 bn investment. [image: GOV UK]

21-Oct-15 With a population of more than one billion and a rapidly developing economy, China is set to become the world’s fastest growing healthcare market. Today’s £2 billion trade package for UK exports in research, hospital construction, training, diagnostics and drug discovery shows the huge potential of UK/Chinese Life Science trade. [image: GOV.UK]

21-Oct-15 GlaxoSmithKline's chief executive is joining a new panel to promote trade between Britain and China, just over a year after the drugmaker was handed a record fine of nearly USD500 mn (GBP323 mn ) for bribing Chinese doctors. The group has since been rebuilding its position in China. [image: Reuters / Luke Macgregor]